Skip to content

Effectiveness of tranexamic acid combined with different antithrombotic agents in total knee arthroplasty

Effectiveness of tranexamic acid combined with different antithrombotic agents in total knee arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060169
Enrollment
Unknown
Registered
2022-05-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:Application of Rivaroxaban
Group 2:Application of Daparin sodium
Group 3:Application of aspirin

Sponsors

Affiliated Hospital of Qinghai University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 55-80 years; 2. Meet the diagnostic criteria for knee osteoarthritis in the Chinese Guidelines for Diagnosis and Treatment of Osteoarthritis (2021 edition); 3. Patients receiving unilateral TKA for the first time.

Exclusion criteria

Exclusion criteria: 1. Secondary osteoarthritis, such as traumatic arthritis, rheumatoid arthritis, gouty arthritis, etc.; 2. There is currently infection in the affected knee joint or other parts of the body; 3. Have blood system diseases; 4. Past or present use of antithrombotic drugs; 5. Previous history of thrombosis or arteriovenous color Doppler ultrasound of lower limbs found thrombosis; 6. High-risk cardiovascular diseases with thrombosis, such as cerebral infarction, myocardial infarction, atrial fibrillation, heart failure, and after stent implantation; 7. The patient had a history of epilepsy and severe hepatic and renal insufficiency.

Design outcomes

Primary

MeasureTime frame
Hemoglobin;Total blood loss;Postoperative drainage;Transfusion rate;Bleeding complications;Thrombotic complications;

Secondary

MeasureTime frame
Platelet;Prothrombin time;Activated partial thromboplastin time;Blood volume;Intraoperative blood loss;

Countries

China

Contacts

Public ContactZhou Libo

Qinghai University

zhoulibo951@163.com+86 18361745679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026